PDCD1 and cancer: A similar analysis was performed on our internal cohort of patients with NSCLC recruited from Yonsei Cancer Center in Korea, which revealed a similar inverse correlation between TOX expression level in the TI T cells and anti-PD-1 responses (Fig. 5g).